Literature DB >> 24184668

Structure-activity relationships of fatty acid amide ligands in activating and desensitizing G protein-coupled receptor 119.

Pritesh Kumar1, Akhilesh Kumar1, Zhao-Hui Song2.   

Abstract

The purpose of the current study was to apply a high throughput assay to investigate the structure-activity relationships of fatty acid amides for activating and desensitizing G protein-coupled receptor 119, a promising therapeutic target for both type 2 diabetes and obesity. A cell-based, homogenous time resolved fluorescence (HTRF) method for measuring G protein-coupled receptor 119-mediated increase of cyclic adenosine monophosphate (cAMP) levels was validated and applied in this study. Using novel fatty acid amides and detailed potency and efficacy analyses, we have demonstrated that degree of saturation in acyl chain and charged head groups of fatty acid amides have profound effects on the ability of these compounds to activate G protein-coupled receptor 119. In addition, we have demonstrated for the first time that pretreatments with G protein-coupled receptor 119 agonists desensitize the receptor and the degrees of desensitization caused by fatty acid amides correlate well with their structure-activity relationships in activating the receptor.
© 2013 Published by Elsevier B.V.

Entities:  

Keywords:  Fatty acid amides; G protein-coupled receptor 119; Structure-activity relationship

Mesh:

Substances:

Year:  2013        PMID: 24184668      PMCID: PMC5086809          DOI: 10.1016/j.ejphar.2013.10.044

Source DB:  PubMed          Journal:  Eur J Pharmacol        ISSN: 0014-2999            Impact factor:   4.432


  20 in total

1.  A Simple Statistical Parameter for Use in Evaluation and Validation of High Throughput Screening Assays.

Authors: 
Journal:  J Biomol Screen       Date:  1999

Review 2.  Regulation of G protein-coupled receptor kinases and arrestins during receptor desensitization.

Authors:  Trudy A Kohout; Robert J Lefkowitz
Journal:  Mol Pharmacol       Date:  2003-01       Impact factor: 4.436

3.  Discovery of the first potent and orally efficacious agonist of the orphan G-protein coupled receptor 119.

Authors:  Graeme Semple; Beatriz Fioravanti; Guillherme Pereira; Imelda Calderon; Jane Uy; Karoline Choi; Yifeng Xiong; Albert Ren; Michael Morgan; Vibha Dave; William Thomsen; David J Unett; Charles Xing; Stuart Bossie; Chris Carroll; Zhi-Liang Chu; Andrew J Grottick; Erin K Hauser; James Leonard; Robert M Jones
Journal:  J Med Chem       Date:  2008-08-13       Impact factor: 7.446

4.  GPR119 regulates murine glucose homeostasis through incretin receptor-dependent and independent mechanisms.

Authors:  Grace Flock; Dianne Holland; Yutaka Seino; Daniel J Drucker
Journal:  Endocrinology       Date:  2010-11-10       Impact factor: 4.736

5.  Identification of raloxifene as a novel CB2 inverse agonist.

Authors:  Pritesh Kumar; Zhao-Hui Song
Journal:  Biochem Biophys Res Commun       Date:  2013-04-20       Impact factor: 3.575

Review 6.  Biology of incretins: GLP-1 and GIP.

Authors:  Laurie L Baggio; Daniel J Drucker
Journal:  Gastroenterology       Date:  2007-05       Impact factor: 22.682

Review 7.  Receptors for acylethanolamides-GPR55 and GPR119.

Authors:  Grzegorz Godlewski; László Offertáler; Jens A Wagner; George Kunos
Journal:  Prostaglandins Other Lipid Mediat       Date:  2009-07-15       Impact factor: 3.072

Review 8.  GPR119 agonists for the treatment of type 2 diabetes.

Authors:  Robert M Jones; James N Leonard; Daniel J Buzard; Juerg Lehmann
Journal:  Expert Opin Ther Pat       Date:  2009-10       Impact factor: 6.674

Review 9.  Novel cannabinoid receptors.

Authors:  A J Brown
Journal:  Br J Pharmacol       Date:  2007-10-01       Impact factor: 8.739

Review 10.  cAMP detection methods in HTS: selecting the best from the rest.

Authors:  Christine Williams
Journal:  Nat Rev Drug Discov       Date:  2004-02       Impact factor: 84.694

View more
  1 in total

1.  A categorical structure-activity relationship analysis of GPR119 ligands.

Authors:  Pritesh Kumar; Carl A Carrasquer; Arren Carter; Zhao-Hui Song; Albert R Cunningham
Journal:  SAR QSAR Environ Res       Date:  2014       Impact factor: 3.000

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.